Electronic digital programmable auditory devices of the behind-the-ear type air sound conduction according to TU 9444-022-93307926-2012 in the following versions: "GRAND-1", "GRAND-2"
- Device Name (English)
- Electronic digital programmable auditory devices of the behind-the-ear type air sound conduction according to TU 9444-022-93307926-2012 in the following versions: "GRAND-1", "GRAND-2"
- Device Name (Russian)
- Аппараты слуховые электронные цифровые программируемые воздушного звукопроведения заушного типа по ТУ 9444-022-93307926-2012 в следующих исполнениях: "ГРАНД-1", "ГРАНД-2"
- Device Type (English)
- N/A
- Device Type (Russian)
- 228560
- Risk Class
- Class 2a
- OKPD Code
- 26.60.14.120
- Registry Key
- 50022.0
- Registration Number
- ФСР 2012/13711
- Registration Date
- January 12, 2021
- Manufacturer Name (English)
- LLC ZSA "RITM"
- Manufacturer Name (Russian)
- ООО ЗСА "РИТМ"
- Country (English)
- Russia
- Country (Russian)
- Россия
- Legal Address (English)
- LLC ZSA "RITM", Russia, 127540, Moscow, Dubninskaya str., 12A
- Legal Address (Russian)
- ООО ЗСА "РИТМ", Россия, 127540, Москва, ул. Дубнинская, д. 12А
- Manufacturing Address
- 115162, Россия, Москва, ул. Хавская, д. 18, к. 2, офис 3, помещ. IV, эт. 4
Access comprehensive regulatory information for Electronic digital programmable auditory devices of the behind-the-ear type air sound conduction according to TU 9444-022-93307926-2012 in the following versions: "GRAND-1", "GRAND-2" in the Russia medical device market through Pure Global AI's free database. This Class 2a medical device is registered under Roszdravnadzor registration number ФСР 2012/13711 and manufactured by LLC ZSA "RITM". The device was registered on January 12, 2021.
This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.